Find Scholarly Works

Search in all content

Filters for Scholarly Works

Search concepts
Selected Filters

Publication Year

  • 2019
  • 2018
  • 2016
  • 2015
  • 2014
  • 2012
  • 2011

Author

  • Keith Lindor

Docetaxel Induced Sclerosing Cholangitis

Horsley-Silva, J. L., Dow, E. N., Menias, C. O., Smith, M. L., Carballido, E. M., Lindor, K. D. & Vargas, H. E., Dec 1 2015, In : Digestive Diseases and Sciences. 60, 12, p. 3814-3816 3 p.

Research output: Contribution to journalArticle

8 Scopus citations
2 Scopus citations

Editorial: Itching to Know: Role of Fibrates in PBC

Levy, C. & Lindor, K., Jan 1 2018, In : The American journal of gastroenterology. 113, 1, p. 56-57 2 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations
8 Scopus citations

Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study

Eaton, J. E., Nelson, K. M., Gossard, A. A., Carey, E. J., Tabibian, J. H., Lindor, K. D. & LaRusso, N. F., May 4 2019, In : Scandinavian Journal of Gastroenterology. 54, 5, p. 633-639 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

Hirschfield, G. M., Mason, A., Luketic, V., Lindor, K., Gordon, S. C., Mayo, M., Kowdley, K. V., Vincent, C., Bodhenheimer, H. C., Parés, A., Trauner, M., Marschall, H. U., Adorini, L., Sciacca, C., Beecher-Jones, T., Castelloe, E., Böhm, O. & Shapiro, D., Apr 1 2015, In : Gastroenterology. 148, 4, p. 751-761.e8

Research output: Contribution to journalArticle

274 Scopus citations

Emerging drugs for the treatment of Primary Biliary Cholangitis

Ali, A. H., Tabibian, J. H., Carey, E. J. & Lindor, K., Jan 2 2016, In : Expert Opinion on Emerging Drugs. 21, 1, p. 39-56 18 p.

Research output: Contribution to journalArticle

12 Scopus citations

Emerging therapeutic targets for primary sclerosing cholangitis

Kalani, A., Tabibian, J. H. & Lindor, K., Jul 3 2018, In : Expert Opinion on Orphan Drugs. 6, 7, p. 393-401 9 p.

Research output: Contribution to journalReview article

Erratum: Primary biliary cirrhosis (Lancet (2015) 386 (1565-1575))

Carey, E. J., Ali, A. H. & Lindor, K., 2015, In : The Lancet. 386, 10003, p. 1536 1 p.

Research output: Contribution to journalArticle

Evaluating sex and gender competencies in the medical curriculum: A case study

Miller, V. M., Flynn, P. M. & Lindor, K. D., Jun 2012, In : Gender Medicine. 9, 3, p. 180-186.e3

Research output: Contribution to journalArticle

12 Scopus citations

Eyewitnesses to history and participants as well

Lindor, K. D., Dec 1 2011, In : Hepatology. 54, 6, 1 p.

Research output: Contribution to journalComment/debate

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

FOLD Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

11 Scopus citations

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K. D., May 1 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

38 Scopus citations

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

the GLOBAL PBC Study Group, Nov 1 2019, In : Alimentary Pharmacology and Therapeutics. 50, 10, p. 1127-1136 10 p.

Research output: Contribution to journalArticle

Open Access
6 Scopus citations

Foreword

Lindor, K., Jan 1 2014, In : Unknown Journal. p. vii-viii

Research output: Contribution to journalArticle

Gall bladder polyps in primary sclerosing cholangitis: Adhere to the guidelines

Gores, G., Lindor, K. D. & Razumilava, N., Jul 1 2012, In : Hepatology. 56, 1, p. 396 1 p.

Research output: Contribution to journalLetter

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K. D., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

134 Scopus citations

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K. D., Nov 1 2011, In : American Journal of Therapeutics. 18, 6, p. e202-e208

Research output: Contribution to journalArticle

21 Scopus citations

Hepatocellular carcinoma: Low risk of HCC in patients who have PSC and cirrhosis

Gossard, A. A. & Lindor, K., May 2014, In : Nature Reviews Gastroenterology and Hepatology. 11, 5, p. 276-277 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K. D., Nov 1 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

60 Scopus citations

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J. & Lindor, K. D., Sep 1 2011, In : American Journal of Gastroenterology. 106, 9, p. 1638-1645 8 p.

Research output: Contribution to journalReview article

162 Scopus citations

Immunoglobulin G4-associated autoimmune cholangiopathy

Lindor, K. D., Apr 1 2011, In : Gastroenterology and Hepatology. 7, 4, p. 259-261 3 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis

Cholankeril, G., Gonzalez, H. C., Satapathy, S. K., Gonzalez, S. A., Hu, M., Khan, M. A., Yoo, E. R., Li, A. A., Kim, D., Nair, S., Wong, R. J., Kwo, P. Y., Harrison, S. A., Younossi, Z. M., Lindor, K. & Ahmed, A., Jun 2018, In : Clinical Gastroenterology and Hepatology. 16, 6, p. 965-973.e2

Research output: Contribution to journalArticle

8 Scopus citations

Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

Fibrotic Liver Disease Consortium Investigators, Aug 1 2018, In : Clinical Gastroenterology and Hepatology. 16, 8, p. 1342-1350.e1

Research output: Contribution to journalArticle

15 Scopus citations

In reply

Reed, D. A. & Lindor, K. D., Aug 2011, In : Academic Medicine. 86, 8, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Is there Still a Role for Ursodeoxycholic Acid Treatment in Patients with Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis?

Sinakos, E. & Lindor, K. D., Jan 30 2012, Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, p. 156-158 3 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Hepatology. 64, 4, p. 1031-1032 2 p.

Research output: Contribution to journalEditorial

4 Scopus citations

Joint society statement for the elimination of viral hepatitis

Brahm, J., Castera, L., Hou, J. & Lindor, K., Oct 1 2016, In : Journal of Hepatology. 65, 4, p. 661-662 2 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Leader's portrait

Lindor, K. D., 2011, In : Clinics and Research in Hepatology and Gastroenterology. 35, 6-7, p. 423-425 3 p.

Research output: Contribution to journalEditorial

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Global PBC Study Group, Dec 1 2014, In : Gastroenterology. 147, 6, p. 1338-1349.e5

Research output: Contribution to journalArticle

172 Scopus citations

Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis

Eaton, J. E., Thackeray, E. W. & Lindor, K. D., Mar 1 2012, In : American Journal of Gastroenterology. 107, 3, p. 431-439 9 p.

Research output: Contribution to journalArticle

51 Scopus citations

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Juliusson, G., Imam, M., Björnsson, E. S., Talwalkar, J. A. & Lindor, K., Jun 2 2016, In : Scandinavian Journal of Gastroenterology. 51, 6, p. 745-752 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Long-term Outcomes of Patients With Primary Biliary Cirrhosis and Hepatocellular Carcinoma

Imam, M. H., Silveira, M. G., Sinakos, E., Gossard, A. A., Jorgensen, R., Keach, J., DeCook, A. C. & Lindor, K. D., Feb 1 2012, In : Clinical Gastroenterology and Hepatology. 10, 2, p. 182-185 4 p.

Research output: Contribution to journalArticle

13 Scopus citations

Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices

Dong, T. S., Kalani, A., Aby, E. S., Le, L., Luu, K., Hauer, M., Kamath, R., Lindor, K. & Tabibian, J. H., Aug 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 9, p. 1894-1901.e1

Research output: Contribution to journalArticle

4 Scopus citations

Magic wand and crystal ball for primary sclerosing cholangitis

Vuppalanchi, R. & Lindor, K., Apr 2014, In : Gastroenterology. 146, 4, p. 890-892 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: Risk factors and time trends in incidence and outcome

Harms, M. H., Lammers, W. J., Thorburn, D., Corpechot, C., Invernizzi, P., Janssen, H. L. A., Battezzati, P. M., Nevens, F., Lindor, K., Floreani, A., Ponsioen, C. Y., Mayo, M. J., Dalekos, G. N., Bruns, T., Parés, A., Mason, A. L., Verhelst, X., Kowdley, K. V., Goet, J. C., Hirschfield, G. M. & 2 others, Hansen, B. E. & Van Buuren, H. R., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 254-264 11 p.

Research output: Contribution to journalArticle

24 Scopus citations

Managing PBC: Expanding the Provider Comfort Zone

Chascsa, D. M. & Lindor, K., Jun 9 2018, (Accepted/In press) In : Digestive Diseases and Sciences. p. 1-2 2 p.

Research output: Contribution to journalArticle

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R. & Lindor, K. D., May 2011, In : Clinical Gastroenterology and Hepatology. 9, 5, p. 434-439.e1

Research output: Contribution to journalArticle

72 Scopus citations

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

on behalf of the GLOBAL PBC Study Group, May 2018, In : Hepatology. 67, 5, p. 1920-1930 11 p.

Research output: Contribution to journalArticle

13 Scopus citations

Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Imam, M. H., Eaton, J. E., Puckett, J. S., Loftus, E. V., Mathis, K. L., Gossard, A. A., Talwalkar, J. A. & Lindor, K., Oct 1 2014, In : Journal of Crohn's and Colitis. 8, 10, p. 1294-1299 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

New treatment strategies for primary sclerosing cholangitis

Lindor, K. D., Jun 1 2011, In : Digestive Diseases. 29, 1, p. 113-116 4 p.

Research output: Contribution to journalArticle

14 Scopus citations

NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A nebulous matter

Tabibian, J. H. & Lindor, K., Jan 1 2019, (Accepted/In press) In : Journal of Hepatology.

Research output: Contribution to journalArticle

3 Scopus citations

Nonalcoholic fatty liver disease and the coronary artery disease

Treeprasertsuk, S., Lopez-Jimenez, F. & Lindor, K. D., Jan 1 2011, In : Digestive Diseases and Sciences. 56, 1, p. 35-45 11 p.

Research output: Contribution to journalReview article

44 Scopus citations

Novel therapeutic targets in primary biliary cirrhosis

Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. & Jones, D. E. J., Mar 6 2015, In : Nature Reviews Gastroenterology and Hepatology. 12, 3, p. 147-158 12 p.

Research output: Contribution to journalReview article

65 Scopus citations

Novel treatments in primary sclerosing cholangitis

Ali, A. H. & Lindor, K., Nov 1 2016, In : Clinical Liver Disease. 8, 5, p. 132-135 4 p.

Research output: Contribution to journalReview article

1 Scopus citations

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis

Harms, M. H., De Veer, R. C., Lammers, W. J., Corpechot, C., Thorburn, D., Janssen, H. L. A., Lindor, K. D., Trivedi, P. J., Hirschfield, G. M., Pares, A., Floreani, A., Mayo, M. J., Invernizzi, P., Battezzati, P. M., Nevens, F., Ponsioen, C. Y., Mason, A. L., Kowdley, K. V., Hansen, B. E., Buuren, H. R. V. & 1 others, Van Der Meer, A. J., 2019, (Accepted/In press) In : Gut. 319057.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis

Silveira, M. G. & Lindor, K., Feb 1 2014, In : Expert Opinion on Pharmacotherapy. 15, 3, p. 365-372 8 p.

Research output: Contribution to journalReview article

30 Scopus citations

Obeticholic acid for the treatment of primary biliary cholangitis

Ali, A. H. & Lindor, K., Sep 1 2016, In : Expert Opinion on Pharmacotherapy. 17, 13, p. 1809-1815 7 p.

Research output: Contribution to journalReview article

21 Scopus citations

Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis

Momah, N., Silveira, M. G., Jorgensen, R., Sinakos, E. & Lindor, K. D., May 1 2012, In : Liver International. 32, 5, p. 790-795 6 p.

Research output: Contribution to journalArticle

38 Scopus citations